Dry AMD Treatment

View All

Dry AMD Emerging Therapies in Therapeutics Market Pegcetacoplan and Zimura
Dry AMD Market: Pegcetacoplan or Zimura, Which Therapy Will Dominate the Market?

The Dry AMD market is a billion-dollar business opportunity today as around 80–90% of individuals are affected by it. As per DelveInsight analysis, there were approximately 34.9 million cases of Dry AMD in 2021. Moreover, in 10–15% of patients with Dry AMD, the deterioration is more rapid and extensive, and they su...

Find More